ResearcherCancerCare ManitobaActive in the last 2 years

Navid Khaledi

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0002-4913-8700; OpenAlex author ID A5017875758.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 1, last author 0)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2024: 1 paper

Papers 1

RBE-based dose planning, and calculation of TCP and NTCP with gold nanoparticles for intermediate photon energy in pancreatic cancer. First author DOI 10.1088/1361-6560/ad68be ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

James L Gräfe · 1 shared paper, 2024
- Paper RBE-based dose planning, and calculation of TCP and NTCP with gold nanoparticles for intermediate photon energy in panc… DOI 10.1088/1361-6560/ad68be ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.